$4.85M Bayer antifungal spray class action settlement

Bayer agreed to pay $4.85 million to resolve claims that Lotrimin and Tinactin antifungal sprays were contaminated with benzene, a known carcinogen.

The Bayer settlement benefits consumers who purchased Lotrimin and Tinactin antifungal spray products that were subject to Bayer’s October 2021 recall. This includes all Lotrimin and Tinactin spray products with lot numbers beginning with TN, CV or NAA, distributed between September 2018 and September 2021.

Products covered by the settlement include:

• Lotrimin Anti-Fungal Athlete’s Foot Powder Spray
  
• Lotrimin Anti-Fungal Jock Itch Powder Spray
  
• Lotrimin Anti-Fungal Athlete’s Foot Deodorant Powder Spray
  
• Lotrimin AF Athlete’s Foot Liquid Spray
  
• Lotrimin AF Athlete’s Foot Daily Prevention Deodorant Powder Spray
  
• Tinactin Jock Itch Powder Spray
  
• Tinactin Athlete’s Foot Deodorant Powder Spray
  
• Tinactin Athlete’s Foot Powder Spray
  
• Tinactin Athlete’s Foot Liquid Spray
  

According to the class action lawsuit, Lotrimin and Tinactin antifungal sprays were contaminated with benzene, a known carcinogen. The presence of benzene in these products allegedly violated state laws and consumer protection statutes.

Bayer is a healthcare and agriculture company that sells a variety of products under different brands, including Lotrimin and Tinactin sprays.

Bayer has not admitted any wrongdoing but agreed to a $4.85 million class action settlement to resolve these allegations.

Under the terms of the Bayer settlement, class members can receive a cash payment based on the number of products they purchased and whether they provide proof of purchase.

With proof of purchase, class members can receive a full refund for the products they purchased. Without proof of purchase, class members can receive $7 per product purchased, with a maximum of three products per household. Payments may be reduced on a pro rata basis depending on the number of claims filed.

Class members who participated in Bayer’s recall program may have their settlement payment reduced by the amount they received through the recall program. However, class members who received three payments under the recall program may be eligible for one no-proof-of-purchase payment.

The deadline for exclusion and objection is March 11, 2026.

The final approval hearing for the antifungal spray settlement is scheduled for May 13, 2026.

To receive a settlement payment, class members must submit a valid claim form by March 11, 2026.

Who’s Eligible

Consumers who purchased a Lotrimin or Tinactin product covered by Bayer’s October 2021 recall, or products purchased from September 2018 to October 2021.

Potential Award

Up to $21

Proof of Purchase

Proof of purchase showing the class member’s actual purchase during the class period of one or more Bayer products (not required for minimum payments of $7 per product)

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

03/11/2026

Case Name

Huertas, et al. v. Aeropres Corp., et al., Case No. 2:21-cv-20021-SRC-CLW, in the U.S. District Court for the District of New Jersey

Final Hearing

05/13/2026

Settlement Website

AntifungalSpraySettlement.com

Claims Administrator

Antifungal Spray Settlement Administrator
c/o Rust Consulting Inc. – 9111
PO Box 2661
Faribault, MN 55021-9661
[email protected]
877-434-3068

Class Counsel

Steven L. Bloch
SILVER GOLUB & TEITELL LLP

Max S. Roberts
BURSOR & FISHER P.A.

Timothy J. Peter
FARUQI & FARUQI LLP

Defense Counsel

Andrew Soukup
COVINGTON & BURLING LLP

Chad Layton
GOLDBERG SEGALLA

Robert Baratta
SMITH, GAMBRELL & RUSSELL, LLP

Timothy Ray
HOLLAND & KNIGHT, LLC

Adam Jagadich
MAREN MARVEL BRADLEY ANDERSON & TARDY LLC